Centurion Wealth Management’s Invesco FTSE RAFI Developed Markets ex-US ETF PXF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.4M Sell
31,451
-10,378
-25% -$807K 0.58% 41
2026
Q2
$3.16M Sell
41,829
-14,700
-26% -$1.11M 0.76% 33
2026
Q1
$3.95M Sell
56,529
-2,890
-5% -$204K 0.89% 27
2025
Q4
$3.89M Buy
59,419
+3,176
+6% +$201K 0.85% 27
2025
Q3
$3.44M Sell
56,243
-287
-0.5% -$17.1K 0.78% 29
2025
Q2
$3.25M Buy
56,530
+20,203
+56% +$1.1M 0.93% 27
2025
Q1
$1.74M Hold
36,327
– – 0.54% 42
2024
Q4
$1.74M Buy
36,327
+5,731
+19% +$285K 0.54% 42
2024
Q3
$1.59M Buy
+30,596
New +$1.54M 0.51% 45

Other funds holding PXF

Centurion Wealth Management's PXF Position: Q3 2026 in Review

Centurion Wealth Management reduced its Invesco FTSE RAFI Developed Markets ex-US ETF (PXF) stake by 25% in Q3 2026, selling an estimated $807K and leaving 31,451 shares worth $2.4M. The position accounts for 0.58% of the portfolio, ranked #41.

Centurion Wealth Management first reported a position in PXF in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.95M in Q1 2026. 38 funds tracked by Wall St. Rank hold PXF as of Q3 2026.

  • Centurion Wealth Management held 31,451 shares of Invesco FTSE RAFI Developed Markets ex-US ETF worth $2.4M as of Q3 2026.
  • Centurion Wealth Management sold 10,378 Invesco FTSE RAFI Developed Markets ex-US ETF shares in Q3 2026, an estimated $807K.
  • Invesco FTSE RAFI Developed Markets ex-US ETF made up 0.58% of Centurion Wealth Management's portfolio in Q3 2026, its #41 holding.
  • Centurion Wealth Management first reported a position in Invesco FTSE RAFI Developed Markets ex-US ETF in Q3 2024 and has held it in 9 quarters since.
  • Centurion Wealth Management's Invesco FTSE RAFI Developed Markets ex-US ETF position peaked at $3.95M in Q1 2026.
  • 38 funds tracked by Wall St. Rank held Invesco FTSE RAFI Developed Markets ex-US ETF as of Q3 2026.

Based on Centurion Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.